Late Breaking News
ATLANTA — Bladder cancer occurs more often than previously expected in patients presenting solely with lower urinary tract symptoms (LUTS) but without hematuria, according to a presentation at the 2013 meeting of the American Urological Association.
IOWA CITY, IA — The proportion of men who were prescribed pharmacotherapy within 90 days of diagnosis of lower urinary tract symptoms (LUTS) and related benign prostate hyperplasia (BPH) at the VA increased from 32.2% in 2003-2004 to 44.8% in 2009-2010.
WASHINGTON - Extremity loss, traumatic brain injury and eye injury each have their own DoD center of excellence, but urotrauma has not received the same policy attention and care coordination as those other types of common injuries, a urologist told a subcommittee of the House Committee on Veterans’ Affairs Committee.
What is the Survival Benefit of PSA Testing?
The question of how and when prostate-specific antigen (PSA) screening for prostate cancer should be used, if at all, is being debated across the medical establishment. Those arguments — and any resolution — will have a significant effect on the VA, which diagnoses more than 12,000 new cases of prostate cancer each year.
Two researchers are trying to better understand the relationship between mental-health issues and lower urinary tract symptoms. Their work in the area began after observing that servicemembers returning from Iraq and Afghanistan had complaints similar to older patients, including urgent incontinence.
Researchers Trying to Understand Why
DURHAM, NC - Researchers are grappling with the results of a new study that shows an association between increased exercise and reduced risk of prostate cancer in white men but not black men.
MINNEAPOLIS — In a rare study that looked at optimal treatment of urinary tract infections (UTI) in men, researchers from the Minneapolis Veterans Health Care System found that treating the condition for more than a week does not appear to reduce risk of recurrence. In fact, they found, when compared with a shorter course of treatment, the longer course can sometimes have some significant downsides.
MINNEAPOLIS — New research out of the Minneapolis VAMC finds that radical prostatectomy does not significantly reduce the risk of death in prostate cancer patients, when compared to observation over more than a decade. While that study confirms other major research on the topic, the controversy about how to treat early-stage prostate cancer continues.
Please read this article and participate in this month's online opinion poll whether radical prostatectomy is overused in early stage prostate cancer at the VA?
GAINESVILLE, FL — Treatment of benign prostatic hyperplasia (BPH), the fourth most common diagnosis among VA patients over 50 years old, has changed radically in the last 15 years, with better management and medications making surgery a less-attractive option in most cases.
Since a report last year of the Army Dismounted Complex Blast Injury Task Force documented a sharp increase in the number of genitourinary (GU) injuries among U.S. warriors in Afghanistan, the DoD has taken several steps to better meet the healthcare needs of these fighters — but much remains to be done.
Most Popular Stories
- Many Healthcare Providers Lose VA Retention Bonuses
- Federal Medicine Organizational Meetings — Tarred with the Same Brush?
- Despite Formulary, High-Cost Diabetes Drug Use Varies Widely Across VA Facilities
- Report Says Administration Faces Hard Choices For Veterans Programs
- Physician Overcomes TBI to Return to Active-Duty Medicine
Join Our E-Mail List